|
|
||||||||
Animal: DNA Viruses |
Laboratoire de Virologie, UPRES EA 2387, CERVI1, Laboratoire de Génétique Moléculaire, Service de Biochimie Médicale2 and Service des Maladies Infectieuses et Tropicales3, Groupe Hospitalier Pitié-Salpêtrière, 83 Bld de lHôpital, 75651 Paris Cedex 13, France
Author for correspondence: Henri Agut. Fax +33 1 42 17 74 11. e-mail henri.agut{at}psl.ap-hop-paris.fr
After serial passage in the presence of increasing concentrations of ganciclovir (GCV) in vitro, a human herpesvirus-6 (HHV-6) mutant exhibiting a decreased sensitivity to the drug was isolated. Analysis of drug susceptibility showed that the IC50 of this mutant was 24-, 52- and 3-fold higher than that of the wild-type (wt) IC50 in the case of GCV, cidofovir and foscarnet, respectively. Genotypic analysis showed two single nucleotide changes as compared to the wild-type: an A
G substitution of the U69 protein kinase (PK) gene resulted in an M318V amino acid substitution and the other change, located in the C-terminal part of the U38 gene, resulted in an A961V amino acid substitution within the DNA polymerase. The M318V change was located within the consensus sequence DISPMN of the putative catalytic domain VI of the PK. This change was homologous to the M460V and M460I changes that had been reported previously within the consensus sequence DITPMN of the human cytomegalovirus (HCMV) UL97 PK and associated with the resistance of HCMV to GCV. The M318V change was also detected by PCR in HHV-6-infected PBMCs from an AIDS patient who had been treated with GCV for a long period of time and exhibited a clinically GCV-resistant HCMV infection. These findings provide strong circumstantial evidence that the M318V change of the PK gene is associated with resistance to GCV and raise the question of cross resistance to this drug among different betaherpesviruses.
This article has been cited by other articles:
![]() |
Y. Isegawa, Y. Miyamoto, Y. Yasuda, K. Semi, K. Tsujimura, R. Fukunaga, A. Ohshima, Y. Horiguchi, Y. Yoneda, and N. Sugimoto Characterization of the Human Herpesvirus 6 U69 Gene Product and Identification of Its Nuclear Localization Signal J. Virol., January 15, 2008; 82(2): 710 - 718. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. De Bolle, L. Naesens, and E. De Clercq Update on Human Herpesvirus 6 Biology, Clinical Features, and Therapy Clin. Microbiol. Rev., January 1, 2005; 18(1): 217 - 245. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mace, C. Manichanh, P. Bonnafous, S. Precigout, D. Boutolleau, A. Gautheret-Dejean, and H. Agut Real-Time PCR as a Versatile Tool for Investigating the Susceptibility of Human Herpesvirus 6 to Antiviral Agents Antimicrob. Agents Chemother., September 1, 2003; 47(9): 3021 - 3024. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.H. Dockrell Human herpesvirus 6: molecular biology and clinical features J. Med. Microbiol., January 1, 2003; 52(1): 5 - 18. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. De Bolle, D. Michel, T. Mertens, C. Manichanh, H. Agut, E. De Clercq, and L. Naesens Role of the Human Herpesvirus 6 U69-Encoded Kinase in the Phosphorylation of Ganciclovir Mol. Pharmacol., September 1, 2002; 62(3): 714 - 721. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |